Buy TRL
Stake TRL
Core Utility & Token Economics

TRL in the Triall ecosystem

TRL Platform Fee

TRL provides access to the Triall platform where it is used to purchase software and services for each new clinical trial.

Lock-up Mechanism

65% of the TRL Platform Fee is locked for the entire duration of the clinical trial.

Burn Mechanism

17.5% of the TRL Platform Fee is permanently burned from the token supply.

Liquidity Boost

The remaining 17.5% is doubled with the reserves of the TRL Treasury and used to increase the liquidity depth of the TRL token market.

Future Utility

Over time, the utility of TRL shall be expanded

Rewards and incentives

For patients and investigator communities. Promoting clinical trial recruitment, retention, and engagement—major issues in the current clinical trial environment.

Monetisation of data assets

Enabling fractional data ownership between Sponsor, CROs, Investigative Sites, and patients.

Payments & Reimbursements

Direct, milestone-based payments and reimbursement, facilitated through programmable contracts and workflows.

Trade TRL

TRL is tradable on the following exchanges

PancakeSwap

TRL / BNB
Token type:
BEP-20
Contract address:

Uniswap

TRL / ETH
Token type:
ERC-20
Contract address:

LBank

TRL / USDT
Token type:
ERC-20, BEP-20
You Likely Have Heard About TRL
The logo of CoinTelegraph.
The logo of Bitcoin.com Podcast.
The logo of Yahoo Finance.
The logo of HackerNoon.
The logo of Real Vision.
The logo of Inverse.
The logo of Emerce.
The logo of AMB Crypto.
The logo of Bitcoinist.
The logo of Cryptos R Us.
Traction

TRL is used in the real world today

6
Clinical Trial Projects
16
Partners
2,300
+
Token Holders
Key TRL metrics
Total Supply:
172,117,836
Circulating Supply:
22,523,274
Total Burned:
2,882,163
Staking Rewards Remaining:
6,787,179
Total Held By Clinical Trial Projects:
108,375
Total T-CRED Balance:
4,250

Last updated: Tue 01 Nov, 2022

Project USPs

Spearheading Web3 technology in clinical trials

First Mover

World’s first to implement blockchain in live and running clinical trials with our successful pilot in 2019.

Industry Experience

Deep understanding of industry needs and trends. Team managed 150+ clinical trials across 30+ countries.

Global Network

Value network of industry partners and potential customers that stretches the globe.

Thought Leader

Published blockchain article in Science and 250+ peer-reviewed papers on innovation in the Life Sciences.

Market Validation

Collaborating with industry-leading stakeholders in our customer domain to build our future vision.

Double-Digit Market

The market for clinical trial software (‘eClinical solutions’) is growing at a CAGR of 13.8%.

Our team

Meet the people behind Triall

Combined, our team has managed 150+ clinical trials across 30+ countries, published about clinical research and innovation in top-tier academic journals such as Nature Biotechnology and Science, and successfully developed companies through all stages of growth, both in the Life Sciences and in the enterprise software domain.

Join Us
Hadil Es-Sbai

Hadil Es-Sbai

CEO

Empathetic and tireless leader with extensive clinical development expertise. Innovator and team builder. Founder of multiple successful service companies in the Life Sciences.

Niels Klomp

Niels Klomp

CTO

Experienced blockchain and SaaS architect. Serial tech-entrepreneur with 15+ years’ experience in various CTO roles. Community-appointed director of the Factom Blockchain, now Accumulate Network.

Joost Flach, PhD

Joost Flach, PhD

Head of Operations

Clinical researcher, project manager and medical writer, operating at the interface between industry and academia. Early blockchain technology enthusiast, dedicated to realising end-user functionalities.

Mark van der Waal

Mark van der Waal

Head of Product & Innovation

PhD candidate and management consultant in health technology innovation with degrees in Biomedical Sciences, Health Technology Assessment, and Business Management. Passionate visual designer with 15 years’ experience in UI, web, and graphic design.

Linda van de Burgwal, PhD

Linda van de Burgwal, PhD

Head of Finance

Academic entrepreneur, project manager and consultant. Co-founder of two successful Life Sciences management consultancies. Director Demonstrator Lab Amsterdam (Zuidas). Holds a cum laude PhD in scientific knowledge valorisation.

Raymond van der Waal

Raymond van der Waal

Head of Strategic Partnerships

Researcher, consultant, and copywriter with a background in Biomedical Sciences and Entrepreneurship. Passion for making complex technologies understandable for a broader audience. Contrary to popular belief, not related to Mark. ;‐)

Cari Jacobs-Blom

Cari Jacobs-Blom

Head of Quality & Compliance

All-round quality manager with 25 yrs of operational, supportive, and managerial experience in clinical research and development. Passionate about training and coaching people and teams.

Arno Bisschop, MD, PhD

Arno Bisschop, MD, PhD

Chief Medical Officer

Medical doctor with 10yrs’ entrepreneurial experience as founder of healthcare and sustainability companies.

Rob Posthumus

Rob Posthumus

General Counsel

Corporate lawyer and deal-maker with extensive experience as legal counsel in the pharma & health care industries. Headed the legal department of Erasmus University Medical Center.

Laura van der Leden

Laura van der Leden

HR, F&A & Office Support

Service-oriented occupational psychologist bringing over 25 yrs of experience as support staff professional. Tailored her skills to the needs of management and employees in small businesses in different B2B services fields.

Advisory Board

Meet our advisors

Join Us
Prof. Niels Chavannes

Prof. Niels Chavannes

LUMC | NeLL

Head of Research, Public Health & Primary Care

Sina Djali

Sina Djali

Janssen Pharmaceuticals (J&J)

Head of Integrated Data Analytics

Dung Trinh, MD

Dung Trinh, MD

Irvine Clinical Research | MdDAO

Chief Medical Officer & Digital Health Entrepreneur

Po Chi Wu, PhD

Po Chi Wu, PhD

UC Berkeley | HKUST

Venture Capitalist & Innovation Advisor

Medium

Our latest articles on Medium

We regularly publish articles about the Triall project on Medium. You may find a selection below.

View all